Join the Scientific Update Newsletter

Dr Jen Crawford at GSK is presenting at our ‘Organic Process R&D Conference’ in New Orleans 22-24 June

We are very pleased to introduce Dr Jen Crawford from GSK.  Jen will be talking about ‘Implementing Statistical Modelling Tools into Early Phase Process Development Workflows’ at our ‘Organic Process Research and Development Conference’ in New Orleans on 22-24 June. This presentation will describe high throughput experiments (HTE) which provide an opportunity to traverse large

Scientific Update speak to Dr Dustin Bringley, Gilead ahead of his presentation at ‘Organic Process Research & Development’ Conference in New Orleans on 22-24 June 2022

The count down has begun and we only have one month to go now until we come to New Orleans for our ‘47th Organic Process R&D Conference’ on 22-24 June. We are so excited about holding this face to face event in such a vibrant brilliant location!  The 3 day meeting will include 16 presentations

Rhodium takes Frigid Phenol to New Heights

Phenols and anilines are two of the most important building blocks in industrial chemical manufacturing. Any process capable of converting one into the other is going to generate a lot of interest, and a paper by Shi and co-workers does just that.1 Direct conversion of an aniline to a phenol is a relatively straightforward transformation

Metal Hydride? NO Protection, NO Problem and NO-Where to Hide

Process chemists at Genentech recently published their work on development of a kilo-scale synthesis of JAK-1 inhibitor- GDC-4379 (Figure 1).1The central heterocyclic core of the molecule consists of a 4-aminopyrazole moiety (elaborated as the pyrazolopyrimidene amide- presumably the inhibitor hinge binding fragment in the kinase active site) with an additional aryl substituent at C-3 and

Scientific Update – changing with the times during covid-19

As businesses around the world have had to postpone and cancel live meetings, conferences and training courses in response to COVID-19 disease, workplace and group training has become one of the earliest and hardest-hit business activities. We have found that 100% of companies we work with across the globe, have had to postpone or cancel their

Interview with Dr David Barnes from Abbvie who is speaking at our Organic Process R&D Conference in Clearwater, Florida 9-11 March.

Dr John Studley (JS) from Scientific Update spoke to Dr David Barnes (DB) from Abbvie in the US  ahead of our ‘Organic Process Research and Development’ Conference which is taking place in Clearwater, Florida on 9-11 March. We are looking forward to your presentation ‘Discovery of Novel Catalytic Technologies in the Development of Complex Clinical

Britest Limited Process Understanding Day

Dr Will Watson Technical Director at Scientific Update Ltd has had an enjoyable few days at the Britest Limited Process Understanding Day in Cheshire. Will was asked to talk about Scientific Update and why companies should invest in their employees professional development. He also highlighted our range of training courses and conferences that we offer to organic chemists worldwide. 

The Good, the Bad and the Ugly.

Dr John Studley, Science Director at Scientific Update and Dr William Goundry from Astra Zeneca got together ahead of our forthcoming Organic Process R&D Conference in Lisbon, Portugal on 23-25 September. Q: Dr John Studley (JS) We are looking forward to your presentation ‘The Good, the Bad and the Ugly! Successes and Failures from the

Working with Britest on a new course on Chemical Engineering

Britest is a leading exponent of whole process design for the chemical, pharma and other process manufacturing industries. We are pleased to be collaborating with Britest on our course ‘Chemical Engineering: What Scientists and other Engineers Need to Know’. This course has been developed, and is presented, by chemical engineers and chemists who specialise in facilitating knowledge

John Studley to join Scientific Update as Scientific Director

Scientific Update is delighted to announce the appointment of Dr John Studley, formerly Head of Process Chemistry for Vertex Pharmaceuticals, UK. John will join the team at Scientific Update in August 2018 as Scientific Director bringing over 20 years’ experience in drug discovery, process chemistry and scale up, having previously worked for Rhone-Poulenc, Oxford Asymmetry and Vertex

19 Close

Filter